Pubblicazioni scientifiche

Rizzo A.; Mollica V.; Santoni M.; Massari F., Risk of selected gastrointestinal toxicities in metastatic renal cell carcinoma patients treated with immuno-TKI combinations: a meta-analysis, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 1225 - 1232 [Articolo in rivista]

Cimadamore A.; Cheng L.; Massari F.; Santoni M.; Pepi L.; Franzese C.; Scarpelli M.; Lopez-Beltran A.; Galosi A.B.; Montironi R., Circulating tumor dna testing for homology recombination repair genes in prostate cancer: From the lab to the clinic, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 15 [Articolo in rivista] Open Access

Santoni M.; Cimadamore A.; Massari F.; Sorgentoni G.; Cheng L.; Lopez-Beltran A.; Battelli N.; Montironi R., Narrative review: Predicting future molecular and clinical profiles of prostate cancer in the United States, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1562 - 1568 [Articolo in rivista] Open Access

Cimadamore A.; Cheng L.; Scarpelli M.; Lopez-Beltran A.; Mollica V.; Montironi R.; Massari F., Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation, «EUROPEAN UROLOGY», 2021, 79, pp. 17 - 19 [Articolo in rivista]

Lopez-Beltran A.; Cimadamore A.; Blanca A.; Massari F.; Vau N.; Scarpelli M.; Cheng L.; Montironi R., Immune checkpoint inhibitors for the treatment of bladder cancer, «CANCERS», 2021, 13, pp. 1 - 16 [Articolo in rivista] Open Access

Montironi R.; Cheng L.; Cimadamore A.; Mazzucchelli R.; Scarpelli M.; Santoni M.; Massari F.; Lopez-Beltran A., Narrative review of prostate cancer grading systems: Will the Gleason scores be replaced by the grade groups?, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1530 - 1540 [Articolo in rivista] Open Access

Cimadamore A.; Cheng L.; Scarpelli M.; Massari F.; Mollica V.; Santoni M.; Lopez-Beltran A.; Montironi R.; Moch H., Towards a new WHO classification of renal cell tumor: What the clinician needs to know-a narrative review, «TRANSLATIONAL ANDROLOGY AND UROLOGY», 2021, 10, pp. 1506 - 1520 [Articolo in rivista] Open Access

Basso U.; Facchinetti A.; Rossi E.; Maruzzo M.; Conteduca V.; Aieta M.; Massari F.; Fraccon A.P.; Mucciarini C.; Sava T.; Santoni M.; Pegoraro C.; Durante E.; Nicodemo M.; Perin A.; Bearz A.; Gatti C.; Fiduccia P.; Diminutto A.; Barile C.; De Giorgi U.; Zamarchi R.; Zagonel V., Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial, «THE ONCOLOGIST», 2021, 26, pp. 740 - 750 [Articolo in rivista]

Rizzo A.; Mollica V.; Massari F., Adjuvant immunotherapy in muscle-invasive urothelial carcinoma, «THE LANCET ONCOLOGY», 2021, 22, pp. 237 - 237 [Articolo in rivista]

Cimadamore A.; Rizzo A.; Mollica V.; Massari F.; Lopez-Beltran A.; Scarpelli M.; Cheng L.; Santoni M.; Montironi R., An update on immunotherapy in uro-oncology, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2021, 6, pp. 229 - 233 [Articolo in rivista]

Santoni M.; Massari F.; Santoni G.; Cimadamore A.; Montironi R.; Battelli N., Re: Human Chimeric Antigen Receptor Macrophages for Cancer Immunotherapy, «EUROPEAN UROLOGY», 2021, 79, pp. 887 - 889 [Articolo in rivista]

Aurilio G.; Santoni M.; Massari F.; Cimadamore A.; Rizzo A.; Mollica V.; Verri E.; Battelli N.; Montironi R., Metabolomic profiling in renal cell carcinoma patients: News and views, «CANCERS», 2021, 13, pp. 1 - 11 [Articolo in rivista] Open Access

Santoni M.; Massari F.; Bracarda S.; Procopio G.; Milella M.; De Giorgi U.; Basso U.; Aurilio G.; Incorvaia L.; Martignetti A.; Rizzo M.; Carteni G.; Grande E.; Matrana M.R.; Crabb S.J.; Vau N.; Sorgentoni G.; Cimadamore A.; Montironi R.; Battelli N., Body mass index in patients treated with cabozantinib for advanced renal cell carcinoma: A new prognostic factor?, «DIAGNOSTICS», 2021, 11, pp. 1 - 10 [Articolo in rivista] Open Access

Rosellini M.; Santoni M.; Mollica V.; Rizzo A.; Cimadamore A.; Scarpelli M.; Storti N.; Battelli N.; Montironi R.; Massari F., Treating prostate cancer by antibody-drug conjugates, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, pp. 1 - 15 [Articolo in rivista] Open Access

Rizzo A.; Mollica V.; Massari F., Re: Thomas Powles, Jonathan E. Rosenberg, Guru P. Sonpavde, et al. Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma. N Engl J Med 2021;384:1125-35, «EUROPEAN UROLOGY ONCOLOGY», 2021, 4, pp. 670 - 670 [Articolo in rivista]

Zong Y.; Montironi R.; Massari F.; Jiang Z.; Lopez-Beltran A.; Wheeler T.M.; Scarpelli M.; Santoni M.; Cimadamore A.; Cheng L., Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives, «EUROPEAN UROLOGY FOCUS», 2021, 7, pp. 955 - 963 [Articolo in rivista]

Santoni M.; Massari F.; Grande E.; Procopio G.; Matrana M.R.; Rizzo M.; De Giorgi U.; Basso U.; Milella M.; Iacovelli R.; Aurilio G.; Incorvaia L.; Buti S.; Caffo O.; Fornarini G.; Carrozza F.; Mollica V.; Rizzo A.; Farag F.; Molina-Cerrillo J.; Battelli N., Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study, «TARGETED ONCOLOGY», 2021, 16, pp. 625 - 632 [Articolo in rivista]

Cimadamore A.; Mazzucchelli R.; Lopez-Beltran A.; Massari F.; Santoni M.; Scarpelli M.; Cheng L.; Montironi R., Prostate cancer in 2021: Novelties in prognostic and therapeutic biomarker evaluation, «CANCERS», 2021, 13, pp. 1 - 12 [Articolo in rivista] Open Access

Rizzo, A; Mollica, V; Massari, F, Adjuvant immunotherapy in muscle-invasive urothelial carcinoma, «THE LANCET ONCOLOGY», 2021, 22, pp. E237 - E237 [Articolo in rivista]

Rizzo A.; Merler S.; Sorgentoni G.; Oderda M.; Mollica V.; Gadaleta-Caldarola G.; Santoni M.; Massari F., Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2021, 17, pp. 1237 - 1243 [Articolo in rivista]